439 related articles for article (PubMed ID: 18759864)
61. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
[TBL] [Abstract][Full Text] [Related]
62. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
Duan SZ; Usher MG; Mortensen RM
Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
[TBL] [Abstract][Full Text] [Related]
63. A therapeutic dose of the lipophilic statin pitavastatin enhances oxidant-induced apoptosis in human vascular smooth muscle cells.
Tsujimoto A; Takemura G; Mikami A; Aoyama T; Ohno T; Maruyama R; Nakagawa M; Minatoguchi S; Fujiwara H
J Cardiovasc Pharmacol; 2006 Oct; 48(4):160-5. PubMed ID: 17086094
[TBL] [Abstract][Full Text] [Related]
64. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
Wang X; Zou Y; Sun A; Xu D; Niu Y; Wang S; Wang K; Ge J
J Cardiovasc Pharmacol; 2007 May; 49(5):253-60. PubMed ID: 17513942
[TBL] [Abstract][Full Text] [Related]
65. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK.
Bao XM; Wu CF; Lu GP
Atherosclerosis; 2010 May; 210(1):114-21. PubMed ID: 20018284
[TBL] [Abstract][Full Text] [Related]
66. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
[TBL] [Abstract][Full Text] [Related]
67. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
[TBL] [Abstract][Full Text] [Related]
68. 2-hydroxy-4'-methoxychalcone inhibits proliferation and inflammation of human aortic smooth muscle cells by increasing the expression of peroxisome proliferator-activated receptor gamma.
Liu CS; Chang CC; Du YC; Chang FR; Wu YC; Chang WC; Hsieh TJ
J Cardiovasc Pharmacol; 2012 Apr; 59(4):339-51. PubMed ID: 22157260
[TBL] [Abstract][Full Text] [Related]
69. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
Saha S; Li Y; Lappas G; Anand-Srivastava MB
J Mol Cell Cardiol; 2008 Feb; 44(2):336-44. PubMed ID: 18162186
[TBL] [Abstract][Full Text] [Related]
70. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity.
Mahadevan VS; Campbell M; McKeown PP; Bayraktutan U
Cardiovasc Res; 2006 Oct; 72(1):60-8. PubMed ID: 16860294
[TBL] [Abstract][Full Text] [Related]
71. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.
Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P
Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036
[TBL] [Abstract][Full Text] [Related]
72. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells.
Cho BJ; Im EK; Kwon JH; Lee KH; Shin HJ; Oh J; Kang SM; Chung JH; Jang Y
Mol Cells; 2005 Dec; 20(3):429-34. PubMed ID: 16404160
[TBL] [Abstract][Full Text] [Related]
73. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner.
Ho-Tin-Noé B; Le Dall J; Gomez D; Louedec L; Vranckx R; El-Bouchtaoui M; Legrès L; Meilhac O; Michel JB
Circ Res; 2011 Oct; 109(9):1003-14. PubMed ID: 21885829
[TBL] [Abstract][Full Text] [Related]
74. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
75. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
[TBL] [Abstract][Full Text] [Related]
76. Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: a proteomic analysis.
Qi YX; Qu MJ; Long DK; Liu B; Yao QP; Chien S; Jiang ZL
Cardiovasc Res; 2008 Oct; 80(1):114-22. PubMed ID: 18540023
[TBL] [Abstract][Full Text] [Related]
77. Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats.
Xiong C; Mou Y; Zhang J; Fu M; Chen YE; Akinbami MA; Cui T
Life Sci; 2005 Oct; 77(24):3037-48. PubMed ID: 15970297
[TBL] [Abstract][Full Text] [Related]
78. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
[TBL] [Abstract][Full Text] [Related]
79. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.
ten Freyhaus H; Huntgeburth M; Wingler K; Schnitker J; Bäumer AT; Vantler M; Bekhite MM; Wartenberg M; Sauer H; Rosenkranz S
Cardiovasc Res; 2006 Jul; 71(2):331-41. PubMed ID: 16545786
[TBL] [Abstract][Full Text] [Related]
80. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
